Paul E. Raether

This profile gathers the share dealings of Paul E. Raether across 3 companies, led by Rockwood Holdings, Inc., Jazz Pharmaceuticals plc and IDEX Corp /DE/. Between 2 February 2006 and 21 July 2008, the trades on record add up to 15 filings.

In open-market terms, that means 1 purchase on one side and 11 sales worth €370.9M on the other. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. So far in 2008, the count stands at 1 purchase and 5 sales.

Most recently, on 22 July 2008, the filings show an open-market purchase in Jazz Pharmaceuticals plc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.